Page last updated: 2024-09-03

gsk peptide and Neoplasms

gsk peptide has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brichard, VG; Lejeune, D1

Reviews

1 review(s) available for gsk peptide and Neoplasms

ArticleYear
GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.
    Vaccine, 2007, Sep-27, Volume: 25 Suppl 2

    Topics: Animals; Biomarkers, Tumor; Cancer Vaccines; Clinical Trials as Topic; Humans; Immunotherapy; Neoplasm Proteins; Neoplasms; Oligopeptides

2007